Table 1.
Baseline | SPC within 3 weeks | 4 weeks | 8 weeks | 12 weeks | 16 weeks | 20 weeks | 24 weeks | Monthly SPC until Death/EOT | 24 weeks after death | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Intervention | |||||||||||
Patient | QLQC-30, LC13, EQ-5D, GHQ-12 | X | X | X | |||||||
SPC review | X | X | X | X | X | X | X | X | |||
Telephone interview (QLQC-30, LC13) | X | X | X | X | |||||||
Carer | GHQ-12, SF-36, FAMCARE-2 | X | X | X | X | ||||||
Control | |||||||||||
Patient | QLQC-30, LC13, EQ-5D, GHQ-12 | X | X | X | |||||||
Telephone interview (QLQC-30, LC13) | X | X | X | X | |||||||
Carer | GHQ-12, SF-36, FAMCARE-2 | X | X | X | X |
EOT = end of trial;EQ-5D = EuroQol-5D;FAMCARE-2 = family satisfaction with advanced cancer care 2; GHQ-12 = General Health Questionnaire-12; LC13 = lung cancer supplement;,QLQ-C30 = Quality of Life Questionnaire Core 30;SF-36 = Short Form 36;SPC = Specialist Palliative Care.